<http://schema.org/description>
"In a couple of years, Amgen\u00A0 will have to face the music when the patent for its $4 billion a year drug, Neulasta, expires in the U.S. and Europe. The patent for sister drug Neupogen has already"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2013/09/12/the-neulasta-question/20719314/>